PHA RMACEUTICAL COMPOUNDING. IJPC media kit. Reach the Decision Makers of Independent, Compounding, and Hospital Pharmacy INTERNATIONAL JOURNAL

Transcription

1 INTERNATIONAL JOURNAL PHA RMACEUTICAL COMPOUNDING IJPC media kit Reach the Decision Makers of Independent, Compounding, and Hospital Pharmacy {An Affiliated Journal of APhA

2 IJPC Delivers the World {Wide Web IJPC.com 60% of all subscription renewals come through IJPC.com Downloadable current and back issues on demand 150,000 page views 46,000 visits 13,000 unique visitors a month Ad Size Price Description (Pixels) (per month) Rectangle 1 (R1) 180 x 150 $200 Rectangle 2 (R2) 180 x 300 $300 Rectangle 3 (R3) 180 x 600 $400 Leaderboard 728 x 90 $500 R1 R2 Leaderboard R3 web ad submission Send Files to: Chris Burr at webmaster@ ijpc.com and advertising@ijpc.com Due Date: Seven (7) days prior to advertising period Border: 1 pixel border Color: RGB Display Text: Maximum of 120 characters of alternate text to be displayed during loading or when images are turned off. Contact info, , phone number, and website URL. File Types: Static: GIF or JPEG; Animated: GIF or Shockwave/Flash Looping: Animation set to 3 loops or less; No audio Maximum Size: 100k; 200k for 180 x 600 A test copy will be sent for inspection and approval prior to placement on the server. Please provide the URL link. Advertisers must have a print advertising contract in order to take advantage of any electronic options (CompoundingToday.com, IJPC.com, CompoundingToday.com Newsletter, and the CNL) CompoundingToday.com A must have paid subscription for any compounding pharmacy or hospital Over 2,000 Formulations or recipes for a compounding/hospital pharmacy 91,000 page views 27,000 visits 11,000 unique visitors a month R3 R1 R2 Description Ad Size Price (Pixels) (per month) Rectangle 1 (R1) 180 x 150 $250 Rectangle 2 (R2) 180 x 300 $375 Rectangle 3 (R3) 180 x 600 $500

3 Meet 12,000 Pharmacists on a Friday Afternoon CompoundingToday.com Weekly E- Newsletter {Advertise Here Have your company s message ed to over 12,000 pharmacists on a Friday afternoon. How s that for efficient? Our readers LOVE to read Dr. Allen s CompoundingToday.com free newsletter. They tell us that they look forward to reading his insightful commentary and finding out what is going on, up to the minute in pharmacy. $400 for each Friday - now that s bang for your buck Description Ad Size (Pixels) Price (Per week) Top Banner 500 x 100 $400 compoundingtoday.com newsletter submission Send Files to: Chris Burr at webmaster@ijpc. com and advertising@ijpc.com Due Date: Seven (7) days prior to advertising period Border: 1 pixel border Color: RGB Display Text: Maximum of 120 characters of alternate text to be displayed during loading or when images are turned off. Contact info, , phone number and website URL. File Types: Static: GIF or JPEG; Animated: GIF upon approval Looping: No looping Maximum Size: 200k Please provide the URL link.

4 A Million s A Month Compounders Network List {CNL {Advertise Here Would you like your company s ad on the top of a million s a month?* Did we mention it s a live link to your website? Be there when our readers share ideas, ask each other questions and post comments. $1,500 for fourteen days. *Expect a half a million views in fourteen days Description Ad Size (Pixels) Price (14 days) Top Banner 500 x 100 $1,500 compounders network list submission Send Files to: Chris Burr at webmaster@ijpc.com and advertising@ijpc.com Due Date: Seven (7) days prior to advertising period Border: 1 pixel border Color: RGB Display Text: Maximum of 120 characters of alternate text to be displayed during loading or when images are turned off. Contact info, , phone number and website URL. File Types: Static: GIF or JPEG; Animated: GIF upon approval Looping: No looping Maximum Size: 200k Please provide the URL link.

5 International Journal of Pharmaceutical Compounding Vol. 14 No. 5 September/October a $5000 over 60 months. Plus recertification of the unit - $ 500 per year. Calculated that the sampler can test two pharmacies per month. (Costs are from June 2009 and may vary based on supplies and purchase volume.) International Journal of Pharmaceutical Compounding Vol. 14 No. 5 September/October 2010 Reach 20,000 Readers Who Want Your Products or Services The International Journal of Pharmaceutical Compounding {IJPC july/august 2009 I N T E R N A T I O N A L J O U R N A L PHA RMACEUTICAL COMPOUNDING advertisement rates Color 1x 3x 6x Inside Front Cover $6,000 $5,400 $5,130 Inside Back Cover $5,300 $4,900 $4,590 Back Cover $6,700 $6,200 $5,780 Premium Positions $6,036 $5,421 $4,806 Full Page Spread $8,350 $7,475 $6,590 Full Page $5,340 $4,805 $4,270 Half Page Spread $5,874 $5,285 $4,697 Half Page (V or H) $3,260 $2,965 $2,670 Third Page (V or H) $2,480 $2,275 $2,070 Quarter Page $2,070 $1,815 $1,670 Premium Position 1: First Right of Table of Contents Premium Position 2: First Right of PreScription Premium Position 3: First Right of First Article (A signed contract is required for rate frequency discounts) 270 The Physiologic Role and Use of Estriol 276 Hormone Treatment Options for Males: What to Do for Men with Low Testosterone 280 Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation hormone replacement therapy 290 Preventing nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients 300 Preparing nonsterile and Sterile Hazardous Compounds in an Institutional Setting VOLUME 13 no. 4 advertisement sizes Size Full Spread Full Page Half Page Third Page Quarter Page Format With Bleed With Bleed No Bleed Horizontal Vertical Spread w/bleed Horizontal Vertical Horizontal Dimensions x x x x x x x x x print submission Send Files to: advertising@ijpc.com Preferred File Format: Press ready PDF Publication Trim Size: 8.5 x (Allow.50 margin) Bleed:.125 on all sides Color: CMYK File Transfer Instructions: Host: ftp://adsftp.ijpc.com Username: ijpc Password: adsforijpc Please advertising@ijpc.com confirming the ad has been uploaded and provide a URL for the ad page on the IJPC Online Edition. Graphic Design: For design or production questions contact Kari Collier at kcollier@ijpc.com Blow-in cards and catalog inserts are available. Please call or for rates. Feature Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Steve Kennedy, PharmD Lisa Linn Siefert, RPh, CMQ/OE Matt Lange, PharmD Walgreens Buffalo Grove, Illinois Abstract Implementation of the United States Pharmacopeia Chapter <797> viable air sampling process can be done via various methods. This multi-site infusion pharmacy organization considered several factors in developing an air-sampling program. This article reviews the factors that should be considered, challenges of implementation, and results of deciding to conduct inhouse testing. A large multi-site organization identified a need to have a cost-effective and efficient program to comply with the United States Pharmacopeia (USP) Chapter <797> requirement of semi-annual viable air sampling. A team of pharmacists, pharmacy technicians, and pharmacy students was established to evaluate the development of an air-sampling program. The team established a plan that consisted of the following actions: g The team developed selection criteria for the two service options internal vs. external testing the criteria of which involved cost considerations, employee involvement, quality of results, and flexibility (see Table 1). We determined that internal testing was the most cost-effective and flexible option, whereas external testing was more convenient for employees with a probable higher quality of results (due to externally trained and experi- The Plan: A revi ew of USP Chapter <797> standards regarding viable air sampling The development of air-sampling d evic e selection criteria A research of testing options: Internal vs. external testing Product information gathering on various air samplers A revi ew of the cost a nd availability data on media Stratification of products based on selection criteria Selection of an air sampler based on criteria The development of procedures a nd the implementation of the process throughout the organization A 12-month post-implementation re-evaluation of the process enced vendors performing the testing from the outset). This organization decided to do internal testing. Key reasons for our decision included: Cost effectiveness of internal testing Greater involvement from pharmacy staff was viewed as a plus to increase their knowledge of the cleanroom environment Flexibility to retest and distribute the sampler to wherever it is needed quickly is important Policies, procedures, and training could be developed to generate quality results. The next step in our process was the comparison of four air sampler products. The organization compared features and benefits of each model (see Table 2). Model B was selected due to the following advantages: Standard contact plates minimized the number of plates on our formulary. The unit and case appeared to be more durable then the other models an important consideration since we would need to ship these units between our pharmacy locations. The customer service from the manufacturer was excellent. The manufacturer was visible at most pharmacy conventions. This proved their commitment to servicing the pharmacy community and allowed us to see and try the units a couple times before committing to it. This organization originally purchased four air samplers, to be shared by approximately 20 pharmacies each, requiring a move between sites every two weeks. The organization s asset Feature Table 1. Service Option Comparison. OptiOns internal testing external testing Cost - $62.50 per site for depreciation of sampler a - Generally a per sampling site fee and a report fee - $2.00 media plate (10 samples) - Costs varied between $500 to $1000 per pharmacy - $18/hour tech time - $40 Shipping - $ per pharmacy Employee involvement - Significant involvement by pharmacy staff - Minimal involvement by pharmacy staff Quality of results - Requires training and strict compliance with - Quality reports and extra assurance due to testing policy and procedures and results by a certified company Flexibility - Allows re-testing and extra sample sites with minimal - Re-testing needs to be scheduled and extra cost additional cost involved Advertise Here tracking system was utilized to monitor air sampler activity. Our final step was to conduct a 12-month post-implementation evaluation, reviewing

6 Who Reads IJPC {and Why it Matters to Your Company Our Readers 20,000 readers IJPC s readers are the pharmacy owners and Directors of Hospital Pharmacy Therefore, THE DECISION MAKERS Paid subscription $140-$175/ year. Not a throw away publication Our readers spend 9 billion dollars annually on cost of goods and services 100% of hospitals compound 79% of all pharmacies compound 5-8% of all prescriptions are compounded; accounting for $12-16 billion dollars in annual sales Who Compounds {and why it matters to your company 100% of hospitals compound 79% of Community Pharmacies compound Community pharmacy prescription sales: $82 billion annually * 5-8% of all prescriptions are compounded (both hospitals and community pharmacy) which represents between $12-16 billion dollars annually *From NCPA Content IJPC is the ONLY journal in the world dedicated to pharmaceutical compounding. It is a peer-reviewed, scientific journal. In every issue there is content on: USP <797> (sterile compounding), USP < 795> (non sterile compounding), Vet, Bio-identical Hormone Replacement Therapy, Pain Management, Formulations, Calculations, Peer Reviewed, and Quality Control. IJPC has published more articles on USP <797> than any other publication in the world. Editorial Calendar January/February Materials Due: March/April Materials Due: May/June Materials Due: July/August Materials Due: September/October Materials Due: November/December Materials Due:

7 Meet IJPC s Editor-in-Chief Loyd V. Allen, Jr., Ph.D., RPh. Dr. Allen is Editor-in-Chief of the International Journal of Pharmaceutical Compounding, CEO of the Midwest Institute of Research and Technology, and Professor Emeritus of the University of Oklahoma HSC College of Pharmacy. He is a consultant to compounding pharmacists and the pharmaceutical industry and currently develops and teaches pharmaceutics courses online at various universities throughout the US. He obtained his B.S. and M.S. in Pharmacy from the University of Oklahoma College of Pharmacy in 1966 and 1970, respectively. He completed a residency in hospital pharmacy at the U.S. Public Health Service Hospital in Boston, MA in He received the Ph.D. in Pharmaceutics from the University of Texas at Austin in He taught at the University of Oklahoma College of Pharmacy (where he opted for early retirement in 1998) where he was Professor and Chair, Department of Medicinal Chemistry and Pharmaceutics. In 1996, he initiated the International Journal of Pharmaceutical Compounding, and serves as Editor-in-Chief. In addition, he is a consultant in pharmacy and pharmaceutics to a number of pharmaceutical companies, and writes for numerous journals and textbooks. Dr. Allen is a Fellow of AFPE(1968), ACA (1995), APhA-APRS(1996), and IACP (1998). He received the J. Leon Lascoff Memorial Award for Outstanding Service to the Profession of Pharmacy in 1998; the highest award given by the American College of Apothecaries. He has also received the AStimulation of Research Award@ from the American Pharmaceutical Association (1998). He has served as a member of the U.S. Pharmacopeia Committee of Revision 1990 to 2000), and is currently serving ( ) on the U.S. Pharmacopeia as Chair of the Expert Committee on Pharmacy Compounding, and as a member of the Nomenclature and Labeling Expert Committee, Standardized Imprint Code Project Team, and the USP Executive Committee. He has also served on the FDA Advisory Committee on Pharmaceutical Compounding. He has served in numerous positions in the APhA Academy of Pharmaceutical Research and Science and served on the APhA Board of Trustees for His research interests are in the areas of drug dosage form design/development and drug stability/ compatibility. He is currently working on both national and international projects involving new drug product formulations. He has supervised 17 M.S. students and 8 Ph.D. students. In addition, he has been awarded 12 patents in the field of drug formulations, with others pending, both nationally and internationally. He has over 100 experimental publications in peer-reviewed scientific journals; over 100 peer-reviewed experimental abstracts; 25 books, chapters and monographs; over 300 professional publications, 21 film/book reviews; co-author on 3 textbooks and sole author of 2 textbooks, currently being revised for the 2nd edition. His textbooks now appear in English, Portuguese and Arabic. He continues to be active in teaching pharmacy courses (both on-site and internet courses) at universities throughout the U.S. and in speaking to professional and scientific organizations nationally and internationally.